Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does shorter duration of chemotherapy worsen survival for elderly patients with colon cancer?

Nature Clinical Practice Oncology volume 4, pages 12–13 (2007)Cite this article

boxed-textNeugut AI et al. (2006) Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol 24: 2368–2375

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sargent DJ et al. (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345: 1091–1097

    Article  CAS  Google Scholar 

  2. Schrag D et al. (2001) Age and adjuvant chemotherapy after surgery for stage III colon cancer. J Natl Cancer Inst 93: 850–857

    Article  CAS  Google Scholar 

  3. Iwashyna TJ and Lamont EB (2002) Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 20: 3992–3998

    Article  CAS  Google Scholar 

  4. Andre T et al. (2004) Oxaliplatin, fluorouracil and leucovorin as adjuvant treatment for colorectal cancer. N Engl J Med 350: 2343–2351

    Article  CAS  Google Scholar 

  5. Chau I et al. (2005) A randomised comparison between 6 months of bolus 5-fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol 16: 549–557

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Carol Lovegrove, Freelance Medical Writer.

Author information

Authors and Affiliations

  1. N Starling is a clinical research fellow and D Cunningham is the Head of the Lymphoma and Gastrointestinal Unit, in the Royal Marsden Hospital, Sutton, UK.,

    Naureen Starling & David Cunningham

Authors
  1. Naureen Starling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Cunningham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Cunningham.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Starling, N., Cunningham, D. Does shorter duration of chemotherapy worsen survival for elderly patients with colon cancer?. Nat Rev Clin Oncol 4, 12–13 (2007). https://doi.org/10.1038/ncponc0667

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0667

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing